Tristen is proud to be a guest lecturer for the Stanford School of Medicine Physician Assistant program
Along with a significant pool of preclinical data on the effect of GLP-1RAs (including exendin-4) on PD models in experimental animals, showing a decrease in the loss of dopaminergic neurons and accumulation of -synuclein in the brain, a decrease in mitochondrial dysfunction and expression of pro-inflammatory mediators such as tumor necrosis factor (TNF)- and interleukin IL-1 [61], promising data from clinical studies on the use of GLP-1RAs in PD have been obtained [62]
Standard therapy may reduce nerve excitability, but pain can persist if mechanical irritation, inflammation, local nerve injury, muscle spasm, metabolic factors, or central sensitization are not addressed together
if those are the deciding factor, a body-scan app may be the better pick
The study was observational, so the researchers can't prove that the medications caused these conditions
Conclusion: Implementing Evidence-Based B12 Therapy for Optimal Outcomes Using evidence-based guidelines for vitamin B12 therapy is key for the best patient results